BUB1 and urinary bladder carcinoma: Targeting BUB1 has been shown to be a promising strategy in osteosarcoma patients, where inhibition of the kinase markedly suppressed cell proliferation, migration, invasion, and induced apoptosis; in bladder cancer, BUB1 inhibition suppressed tumour progression30.